Navigation Links
2013 Global Medical Devices Outlook

NEW YORK, July 31, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

2013 Global Medical Devices Outlook

Positioning for the Future

This 2013 Frost & Sullivan outlook study provides projections for the global medical devices market. Specifically, the research included identifies market sectors and sub-sectors poised for expansion; discusses key opportunities in emerging markets; identifies the four Rs in the medical device spectrum; and covers strategies for success in the new market paradigm. A timeline of the future of medical technology development is included as are the competitor landscape and a critical country analysis as well as the impact of technology trends. Final thoughts include new marketplace strategies for success and implications for organizations in this industry.

Top-five Growth Sectors

Structural Heart

New technologies, including transcatheter valves and congestive heart failure products, are poised to expand access of care to high-risk patients, who otherwise had no options.

Robotic Assistance

Higher levels of specialty training, coupled with newer and more advanced solutions, are expected to bolster growth in robot-assisted technologies for surgery and treatment planning.

Infection Control Tools

The attention paid to hospital acquired infections (HAI) and associated costs continues to intensify the market appetite for new tools and systems for reducing occurrences.

Home Care

Wellness initiatives, remote monitoring tools, and a push to extend care outside of hospital walls are spurring rapid advancement in novel medical products that can be used in home care settings.


Significant expansion of interventional and implantable medical devices to treat brain disorders is expected as new technologies are able to advance care beyond current standards.

Top-five Technology Trends


The rise of new technologies capable of integrating medical devices into a connected platform enhances the functionality of devices, reduces man power burden, and minimizes errors.


Due to price sensitivity and availability of floor space, highly-specialized pieces of equipment are losing out in purchase decision making to versatile systems capable of addressing multiple needs.

Big Data

The amount of health care data being captured due to recent IT infrastructure upgrades is expected to greatly enhance 'smart' and AI functionality for diagnostic and treatment devices.

Low-cost Alternates

Cost-containment initiatives are spurring new types of innovation in medical technologies that provide comparable diagnostic and therapeutic utility at fractions of the cost.


Nanotechnology provides the benefits of biocompatibility and functionality at an unparalleled scale, allowing it to be better able to influence diseases happening at a cellular level.

Five Companies to Watch in 2013

Johnson & Johnson

Major restructuring of the company in 2012 introduced a new CEO and the consolidation of multiple device franchises into three units. Aggressive portfolio management is expected in 2013 as it sheds sluggish businesses and enters into new markets via acquisitions.


Medtronic's 2012 Kanghui acquisition exemplifies the emphasis of emerging markets in the company's long term vision. In the US, expected 2013 approvals for transcatheter and renal denervation technologies would provide access to two hot-growth treatments.


In early 2013, Stryker announced acquisition of a Chinese orthopedic implant developer. Value-based devices and access to emerging markets are increasingly driving industry M&A activity. Stryker is also expected to make a play in robot assisted surgery as well.


Covidien has been steadily building its portfolio of products via acquisitions to transition from commoditized markets to those with significant growth potential. Now that it has established a presence, the company is expected to be much more aggressive in capturing share.

St. Jude Medical

While St. Jude Medical faces weakening sales for its core markets of pacemakers, ICDs, and artificial heart valves, it is well-positioned in the hot-growth markets of transcatheter valves, fractional flow reserve (FFR) testing, cardiac ablation, neuromodulation, and renal denervation.

CEO's Perspective

1. Cutting costs and internal resource management are more critical to market viability than a growing top line.2. Shifts in healthcare spending change the factors impacting market traction making innovation necessary.3. Overhaul sales strategies to optimize for a consolidated customer base are driven by outcomes and value.4. Maximizing emerging market strategies are achieved by targeting regions and cities, not countries.5. The role of the patient is more important in determining treatment and burden of pay for healthcare services.

Three Big Predictions for 2013

1. A hyper-pressurized, cost-containment environment will likely accelerate cost-cutting measures from companies adjusting to the realities of the new marketplace.2. Patient influence in treatment selection is magnified due to increasing access to information and greater shifts in financial burden. The launch of health exchanges and rollbacks in employer-covered plans could lead to more distinct tiers of coverage.3. Emerging market needs drive decision making for companies regarding mergers and acquisition (M&A) strategy and product development. With financial resources and on-the-ground infrastructure previously required, companies found it difficult to fully invest in emerging market strategies.

Medical Devices Market Outlook

2012 was a year of transition for the industry as a number of macroeconomic and regulatory events came to a head. The industry essentially closed the chapter on a market era, starting in the mid 1990s that included an explosion of new technologies, advances in care, and significant market expansion. In that time period, with the majority of growth occurring in established markets of the US, Western Europe, and Japan companies were easily able to focus and funnel resources. For an industry tied to government spending for a significant portion of services that unbridled growth quickly becomes unsustainable. As historic demand for services were compounded with higher costs of care per service, the market quickly hit a saturation point that led to reimbursement caps in the US, and austerity measures in Europe.

Looking forward, 2013 seems to be the beginning of a new era in the marketplace that is more sensitive to the value of care. Historically, the market needle was tied nearly exclusively to the launch of new and groundbreaking products that could advance current treatment paradigms. While the opportunities for those sorts of developments still exist, the threshold has shifted for what constitutes an advancement in the market is willing to justify increased spending for. Due to continued pricing pressure, profitability will depend on more sophisticated market strategy related maneuverings to position product offerings for value-conscious consumers.

Market Forecast Discussion Market forecasts for the medical technology market can vary greatly depending on segmentation. Frost & Sullivan projects a base year market estimate of the global medical technologies market at $X billion, with an end of forecast period projection of $Xbillion in 2017.

Therapeutic medical devices, which make up the primary focus of this outlook, account for approximately X% of the total aggregate medical technologies market. Other segments of the market include diagnostic tools, patient monitoring equipment and supplies, and advanced medical imaging equipment and accessories.

The market witnessed a slowdown from 2008–2011, triggered by the economic recession, which resulted in cost-containment measures in the US, austerity measures in Europe, and market stagnation in Japan. Those pressures are unlikely to ease in the near term. While there are opportunities for certain new treatments, most mature markets could see a gradual decline as reimbursement cuts are enacted.

Growth strategies in emerging markets have proven critical to long-term success for most upper-tier medical device manufacturers. Despite the clear opportunity, the differences in healthcare systems on a country by country basis have made execution of strategies challenging.

Table Of Contents 1. Executive Summary

2. The Big Picture: Industry Transition

3. Competitor Landscape

4. Challenges and Strategies

5. Technology Trends and Future Market Directions

6. Critical Country Analysis

7. Final Thoughts

8. The Frost & Sullivan Story

To order this report:Medical_Devices Industry: 2013 Global Medical Devices Outlook

Contact Clare:
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Blood Pressure Monitoring And Measurement Instruments Industry
2. Astellas Appoints New Senior Vice President of Global Oncology Development
3. PSI Extends Global Presence to South Africa
4. Global Computed Tomography: Market Shares, Strategies, and Forecasts to 2018
5. MRIGlobal, Evogen Announce Agreement In Development Of Diagnostic Solutions
6. The Global Healthcare IT Market Report - North America Commands Highest Market Share However Asia-Pacific Set to Have the Highest CAGR
7. Global Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts to 2018
8. Global Mechanical Ventilators Industry
9. Covance Central Laboratory Services Again Ranks #1 in Global Investigator Satisfaction Survey
10. Global Industrial X-Ray Inspection Systems Industry
11. Global Intraocular Lenses Industry
Post Your Comments:
(Date:11/25/2015)... -- The total global healthcare industry is expected to grow at ... America has the highest projected growth at 12.7%, ... ), is second with growth projected at 11.5%. ... expenditure. In 2013-2014, total government funded healthcare was nearly 68%. ... 41.2% in 2013-2014. In real terms, out of pocket expenditure ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
(Date:11/25/2015)... USA , Inc., a leader in ... accuracy of its blood glucose meter systems. Last week ... Cardiovascular Disease in Los Angeles , ... 01 meter and the Assure ® Prism multi-user ... measure glucose levels in blood is essential for people ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the ... 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the ... Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention Center ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... mental health and wellness consultation, has collaborated with Women’s Web – an ... reader’s queries on topics on mental and emotional well-being relationship, life balance, ...
(Date:11/25/2015)... Ill. (PRWEB) , ... November 25, 2015 , ... ... and potentially more aggressive than those found on mammography, according to a study ... findings of additional cancers not seen on mammography may necessitate a change in ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... gatherings where preparing the perfect dish and pleasing the palates of attendees is ... or bringing a dish to a seasonal get-together, give these recipes a try ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... companies, has been recognized once again for its stellar workplace culture with the ... Work.” , Medical Solutions’ Cincinnati office was named a finalist in ...
Breaking Medicine News(10 mins):